Emerging antiarrhythmic drug therapy for atrial fibrillation
Authors:
Open Access
- 13 September 2025
- journal article
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (11) , 1686-1687
Abstract
No abstract availableKeywords
Funding Information
- Massachusetts General Hospital
This publication has 5 references indexed in Scilit:
- Arrhythmia Recurrence and Rhythm Control Strategies After Catheter Ablation of Newly Diagnosed Atrial Fibrillation (ARRC-AF Study)JACC: Clinical Electrophysiology, 2025
- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCirculation, 2024
- The Increasing Role of Rhythm Control in Patients With Atrial FibrillationJACC, 2022
- A Comparison of Rate Control and Rhythm Control in Patients with Atrial FibrillationNew England Journal of Medicine, 2002
- ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and ElectrophysiologyCirculation, 2001